TOPICS
Marketing Automation for Biotech & Pharma
DIRECT ANSWER
Marketing automation is software that executes marketing tasks—sending emails, updating CRM records, triggering ad audiences, scoring leads—based on rules or schedules, without requiring manual action for each event. It handles repetitive, high-volume execution so marketing teams can focus on strategy, creative, and decisions that require judgment. For Biotech & Pharma companies, this matters because Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch.
What marketing automation means for Biotech & Pharma
The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.
For Biotech & Pharma teams the relevant marketing pains are: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute
What marketing automation platforms do
Core automation platforms (HubSpot, Marketo, Pardot, ActiveCampaign, Klaviyo) share a common set of capabilities: contact database, email send engine, workflow builder, landing page and form tools, CRM sync, and basic reporting. Workflows are the operational unit: define a trigger (form submitted, page visited, deal stage changed), a condition (contact is in target industry, lead score exceeds threshold), and an action (send email, notify sales rep, add to ad audience, update field).
The market is large and well-established. Grandview Research estimated the global marketing automation market at $5.2 billion in 2022 with a CAGR of roughly 13% through 2030. Penetration among mid-market and enterprise B2B companies is high—Emailmonday research has put adoption above 56% among B2B organizations. Despite high adoption, underutilization is a consistent pattern: most teams use 20–30% of their platform's capability, primarily email sends and lead routing, while more sophisticated features like predictive scoring and dynamic content go unused.
Running marketing automation for Biotech & Pharma with CoMo
CoMo's agents apply marketing automation across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships for Biotech & Pharma companies — tuned to VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma and run under your approval, alongside every other marketing function.
FAQ
Marketing Automation for Biotech & Pharma — common questions
What is the difference between marketing automation and a CRM?
A CRM is a database and pipeline management tool focused on sales activity—contacts, deals, tasks, call logs. Marketing automation is an execution engine focused on outbound engagement—email sends, workflows, lead scoring, ad audiences. Most modern stacks integrate both, and several platforms (HubSpot, Salesforce) offer both in one product.
How does marketing automation differ for Biotech & Pharma companies?
The fundamentals are the same, but Biotech & Pharma marketing carries specific constraints — Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch and FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute. CoMo adapts execution to that context automatically.
BUILT BY COMO'S AGENTS
This page was written by CoMo — the autonomous CMO.
CoMo runs every channel of your marketing on your live data. See it work on your brand.